PFIZER.NS Balance Sheet
Pfizer Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:42
| Line item | FY2022-23 standalone basis | FY2023-24 standalone basis | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹177.53 Cr. | ₹150.95 Cr. | ₹171.82 Cr. | ₹136.13 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹7.93 Cr. | ₹0.40 Cr. | ₹7.64 Cr. | ₹20.00 Cr. | CapitalWorkInProgress |
| Goodwill | ₹527.49 Cr. | ₹527.49 Cr. | ₹527.49 Cr. | ₹527.49 Cr. | Goodwill |
| Other Intangible Assets | ₹44.23 Cr. | ₹34.27 Cr. | ₹24.31 Cr. | ₹14.35 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹607.77 Cr. | ₹677.89 Cr. | ₹583.77 Cr. | ₹333.19 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹1,475.64 Cr. | ₹1,459.22 Cr. | ₹1,398.26 Cr. | ₹1,118.66 Cr. | NoncurrentAssets |
| Inventories | ₹417.70 Cr. | ₹433.69 Cr. | ₹475.92 Cr. | ₹472.66 Cr. | Inventories |
| Trade Receivables | ₹151.73 Cr. | ₹187.61 Cr. | ₹193.09 Cr. | ₹181.80 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹36.60 Cr. | ₹112.00 Cr. | ₹495.07 Cr. | ₹102.66 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹0.00 Cr. | ₹56.78 Cr. | ₹38.96 Cr. | ₹35.03 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹2,493.34 Cr. | ₹2,737.81 Cr. | ₹3,512.85 Cr. | ₹3,803.22 Cr. | CurrentAssets |
| Total Assets | ₹4,000.73 Cr. | ₹4,228.78 Cr. | ₹4,911.11 Cr. | ₹4,921.88 Cr. | Assets |
| Equity Share Capital | ₹45.75 Cr. | ₹45.75 Cr. | ₹45.75 Cr. | ₹45.75 Cr. | EquityShareCapital |
| Other Equity | ₹3,161.55 Cr. | ₹3,549.79 Cr. | ₹4,171.66 Cr. | ₹4,157.15 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹3,207.30 Cr. | ₹3,595.54 Cr. | ₹4,217.41 Cr. | ₹4,202.90 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | N/A | N/A | N/A | NonControllingInterest |
| Total Equity | ₹3,207.30 Cr. | ₹3,595.54 Cr. | ₹4,217.41 Cr. | ₹4,202.90 Cr. | Equity |
| Long-term Borrowings | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹136.08 Cr. | ₹86.68 Cr. | ₹124.19 Cr. | ₹91.50 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹2.50 Cr. | ₹2.50 Cr. | ₹2.50 Cr. | ₹2.50 Cr. | BorrowingsCurrent |
| Trade Payables | ₹217.06 Cr. | ₹166.23 Cr. | ₹151.60 Cr. | ₹215.94 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹74.36 Cr. | ₹135.29 Cr. | ₹64.76 Cr. | ₹45.62 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹657.35 Cr. | ₹546.56 Cr. | ₹569.51 Cr. | ₹627.48 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹4,000.73 Cr. | ₹4,228.78 Cr. | ₹4,911.11 Cr. | ₹4,921.88 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from PFIZER.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).